Free fatty acids, cardiovascular mortality, and cardiometabolic stress

European Heart Journal

Volumn 28, Issue 22, 2007, Pages 2699-2700

  Mozaffarian, Dariush ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; EDITORIAL; FOLLOW UP; HEART INFARCTION; HUMAN; LIPOLYSIS; METABOLIC STRESS; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; DEATH, SUDDEN, CARDIAC; FATTY ACIDS, NONESTERIFIED; HUMANS;

EID: 36248955161     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm451     Document Type: Editorial

References (14)

1. Pilz S, Scharnagl H, Tiran B, Wellnitz B, Seelhorst U, Boehm BO, März W. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J 2007;28:2763-2769. First Published on August 31, 2007, doi: 10.1093/eurheartj/ehm343.
2. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, März W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006;91:2542-2547.
3. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999;99:1978-1983.
4. Blaak EE. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 2003;62:753-760.
5. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 2006;6:177-181.
6. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005;85:1093-1129.
7. Oliver MF. Sudden cardiac death: the lost fatty acid hypothesis. Q J Med 2006;99:701-709.
8. Gregor MF, Hotamisligil GS. Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 2007;48:1905-1914.
9. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK; American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Rehabilitation, and Prevention; American Heart Association Council on Nutrition, Physical Activity, and Metabolism Subcommittee on Physical Activity. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-3116.
10. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-785.
11. Jacobs DR Jr, Gallaher DD. Whole grain intake and cardiovascular disease: a review. Curr Atheroscler Rep 2004;6:415-423.
12. Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M; Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005;28:888-894.
13. Estruch R, Mártinez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, Fiol M, Gómez-Gracia E, López-Sabater MC, Vinyoles E, Aros F, Conde M, Lahoz C, Lapetra J, Sáez G, Ros E; PREDIMED Study Investigastors. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006;145:1-11.
14. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.